304 related articles for article (PubMed ID: 26854840)
1. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis.
Ruggeri RM; Vicchio TM; Cristani M; Certo R; Caccamo D; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
Thyroid; 2016 Apr; 26(4):504-11. PubMed ID: 26854840
[TBL] [Abstract][Full Text] [Related]
2. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.
Ruggeri RM; Cristani M; Vicchio TM; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
J Endocrinol Invest; 2019 Feb; 42(2):199-205. PubMed ID: 29796799
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
4. Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Reduced in Euthyroid Children with Newly Diagnosed Hashimoto's Thyroiditis: A Pilot Study.
Aversa T; Ruggeri RM; Corica D; Cristani MT; Pepe G; Vicchio TM; Alibrandi A; Trimarchi F; Cannavò S; Pajno GB; Wasniewska MG
Horm Res Paediatr; 2021; 94(3-4):144-150. PubMed ID: 34237741
[TBL] [Abstract][Full Text] [Related]
5. Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis.
Ruggeri RM; Giovinazzo S; Barbalace MC; Cristani M; Alibrandi A; Vicchio TM; Giuffrida G; Aguennouz MH; Malaguti M; Angeloni C; Trimarchi F; Hrelia S; Campennì A; Cannavò S
Thyroid; 2021 Jan; 31(1):96-105. PubMed ID: 32729374
[No Abstract] [Full Text] [Related]
6. Serum anti-Müllerian hormone levels in euthyroid adolescent girls with Hashimoto's thyroiditis: relationship to antioxidant status.
Erol O; Parlak M; Ellidağ HY; Parlak AE; Derbent AU; Eren E; Yılmaz N
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():204-9. PubMed ID: 27343736
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oxidative stress in Hashimoto's thyroiditis: inter-relationships to biomarkers of thyroid function.
Rostami R; Aghasi MR; Mohammadi A; Nourooz-Zadeh J
Clin Biochem; 2013 Mar; 46(4-5):308-12. PubMed ID: 23219737
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of paraoxonase activity and association with serum advanced glycation end products as reliable markers of oxidative stress in Hashimoto's thyroiditis.
Ruggeri RM; Cristani MT; Crupi F; Molonia MS; Burduja N; Alibrandi A; Campennì A; Cannavò S
Minerva Endocrinol (Torino); 2022 Oct; ():. PubMed ID: 36251022
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
Li D; Liang G; Calderone R; Bellanti JA
Med Hypotheses; 2019 Jul; 128():69-75. PubMed ID: 31203913
[TBL] [Abstract][Full Text] [Related]
10. Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis.
Konca Degertekin C; Aktas Yilmaz B; Balos Toruner F; Kalkanci A; Turhan Iyidir O; Fidan I; Yesilyurt E; Cakır N; Kustimur S; Arslan M
Cytokine; 2016 Apr; 80():13-7. PubMed ID: 26928603
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Csiha S; Molnár I; Halmi S; Hutkai D; Lőrincz H; Somodi S; Katkó M; Harangi M; Paragh G; Nagy EV; Berta E; Bodor M
Front Endocrinol (Lausanne); 2023; 14():1187725. PubMed ID: 37305044
[TBL] [Abstract][Full Text] [Related]
12. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
[TBL] [Abstract][Full Text] [Related]
13. One-year prophylactic treatment of euthyroid Hashimoto's thyroiditis patients with levothyroxine: is there a benefit?
Padberg S; Heller K; Usadel KH; Schumm-Draeger PM
Thyroid; 2001 Mar; 11(3):249-55. PubMed ID: 11327616
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress markers in patients with hymenoptera venom allergy.
Patella V; Incorvaia C; Minciullo PL; Oricchio C; Saitta S; Florio G; Saija A; Gangemi S
Allergy Asthma Proc; 2015; 36(1):9-13. PubMed ID: 25562550
[TBL] [Abstract][Full Text] [Related]
15. The relationship between oxidative stress and autoimmunity in Hashimoto's thyroiditis.
Ates I; Yilmaz FM; Altay M; Yilmaz N; Berker D; Güler S
Eur J Endocrinol; 2015 Dec; 173(6):791-9. PubMed ID: 26340971
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
17. The association between thyroid volume, L-thyroxine therapy and hepatocyte growth factor levels among patients with euthyroid and hypothyroid goitrous and non-goitrous Hashimoto's thyroiditis versus healthy subjects.
Kilic MK; Yesilkaya Y; Tezcan K; Cinar N; Akin S; Karakaya J; Akata D; Usman A; Gurlek A
Endocr Res; 2016 May; 41(2):110-5. PubMed ID: 26726836
[TBL] [Abstract][Full Text] [Related]
18. RAGE polymorphisms and oxidative stress levels in Hashimoto's thyroiditis.
Giannakou M; Saltiki K; Mantzou E; Loukari E; Philippou G; Terzidis K; Lili K; Stavrianos C; Kyprianou M; Alevizaki M
Eur J Clin Invest; 2017 May; 47(5):341-347. PubMed ID: 28226412
[TBL] [Abstract][Full Text] [Related]
19. The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto's thyroiditis.
Ates I; Altay M; Yilmaz FM; Topcuoglu C; Yilmaz N; Berker D; Guler S
Eur J Endocrinol; 2016 Jun; 174(6):727-34. PubMed ID: 26951600
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies.
Peluso R; Lupoli GA; Del Puente A; Iervolino S; Bruner V; Lupoli R; Di Minno MN; Foglia F; Scarpa R; Lupoli G
J Rheumatol; 2011 Jul; 38(7):1371-7. PubMed ID: 21498480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
